51.2 Chronic Valvular Heart Disease & Murmur Evaluation

ABFM Family Medicine Certification Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Blueprint & Clinical Decision-Making

1.1 Exam Blueprint, FMCLA vs. One-Day Exam & Board Scoring 1.2 Clinical Reasoning, Test-Taking Strategy & Ambiguity Management 1.3 Evidence-Based Medicine & Clinical Practice Guidelines in Primary Care

2 Chapter 2: Healthcare Systems, Practice Management & Quality

2.1 Practice Management, Billing, Coding & Documentation 2.2 Quality Improvement, Patient Safety & Diagnostic Stewardship 2.3 Interprofessional Team-Based Care & Care Coordination

3 Chapter 3: Ethics, Law, Biostatistics & Health Equity

3.1 Medical Ethics, Informed Consent & Surrogate Decision-Making 3.2 Biostatistics, Clinical Epidemiology & Diagnostic Test Interpretation 3.3 Social Determinants of Health, Health Equity & Cultural Humility 3.4 Physician Wellness, Burnout Prevention & Professionalism

4 Chapter 4: Lifestyle Counseling & Behavior Change

4.1 Alcohol Use Screening & Brief Intervention 4.2 Illicit Drug & Cannabis Counseling 4.3 Tobacco & Vaping Cessation Counseling

5 Chapter 5: Nutrition, Physical Activity & Chronic Disease Prevention

5.1 Dietary Counseling for Obesity & Chronic Disease Prevention 5.2 Exercise Prescription & Physical Activity Counseling 5.3 Genetic Risk Assessment & Family History Counseling

6 Chapter 6: Routine Adult Immunizations

6.1 ACIP Adult Respiratory Vaccines: Influenza, COVID-19, RSV & Pneumococcal 6.2 ACIP Adult Non-Respiratory Vaccines: Tdap, Shingrix, HPV & Hep B 6.3 Immunizations in Special Populations: Pregnancy, Asplenia & Immunocompromise

7 Chapter 7: Pediatric Health Maintenance & Surveillance

7.1 Newborn Examination & Early Postnatal Care 7.2 Well-Child Care, Developmental Surveillance & Milestones 7.3 Pediatric & Adolescent Screening: Vision, Hearing, Anemia & Lead 7.4 Pediatric Oral Health, Dental Screening & Fluoride

8 Chapter 8: Behavioral Health & Safety Screening

8.1 Primary Care Depression, Anxiety & Behavioral Health Screening 8.2 Domestic Violence, Intimate Partner Violence & Firearm Safety 8.3 Occupational Health & Recreational Safety Counseling

9 Chapter 9: Adult Preventive Screening: Cardiovascular & Metabolic

9.1 Cardiovascular Disease & Hypertension Screening 9.2 Type 2 Diabetes Screening & Prediabetes Risk Stratification 9.3 Abdominal Aortic Aneurysm & Osteoporosis Screening

10 Chapter 10: Adult Cancer Screening: Breast & Gynecologic

10.1 Breast Cancer Screening & Risk-Assessment 10.2 Cervical Cancer Screening & ASCCP Algorithms 10.3 Skin Cancer Clinical Assessment & Counseling

11 Chapter 11: Adult Cancer Screening: Colorectal, Lung & Prostate

11.1 Colorectal Cancer Screening Modalities & Intervals 11.2 Lung Cancer Screening with Low-Dose CT 11.3 Prostate Cancer Screening & Shared Decision-Making

12 Chapter 12: Sexual Health, Infectious Disease Screening & Contraception

12.1 Sexual Health Counseling & Risk-Reduction Strategies 12.2 STI Screening: Chlamydia, Gonorrhea, Syphilis & Trichomoniasis 12.3 Bloodborne Infectious Disease Screening: HIV & Hepatitis C

13 Chapter 13: Reproductive Life Planning, Lactation & Preoperative Care

13.1 Preconception Planning & Comprehensive Contraception Management 13.2 Lactation Support & Breastfeeding Counseling 13.3 Preoperative Medical Evaluation & Pre-Participation Sports Exam

14 Chapter 14: Emergent Cardiovascular Conditions

14.1 Acute Coronary Syndromes & Myocardial Infarction 14.2 Acute Chest Pain Risk Stratification & Triage 14.3 Acute or Critical Valvular Heart Emergencies

15 Chapter 15: Cardiac Arrhythmias, Heart Failure & Hypertensive Crises

15.1 Acute Atrial & Ventricular Arrhythmias 15.2 Acute Decompensated Heart Failure & Cardiogenic Shock 15.3 Hypertensive Emergency & Urgency Management

16 Chapter 16: Vascular & Thromboembolic Emergencies

16.1 Pulmonary Embolism & Deep Vein Thrombosis 16.2 Acute Aortic Syndromes & Peripheral Vascular Emergencies 16.3 Critical Limb Ischemia & Acute Arterial Occlusion

17 Chapter 17: Neurologic Emergencies: Stroke & Altered Consciousness

17.1 Acute Ischemic Stroke & Intracranial Hemorrhage 17.2 Syncope Evaluation & Status Epilepticus 17.3 Acute Delirium, Encephalopathy & Severe Confusion

18 Chapter 18: Neurologic Trauma & Acute Cranial Emergencies

18.1 Concussion, Moderate-to-Severe TBI & Intracranial Injury 18.2 Thunderclap & Acute Severe Secondary Headaches 18.3 Acute Ophthalmologic Emergencies

19 Chapter 19: Acute Abdominal, Pelvic & Gastrointestinal Emergencies

19.1 Acute Abdominal & Pelvic Pain Triage 19.2 Upper & Lower Gastrointestinal Bleeding 19.3 Acute Hepatic Failure, Cholangitis & Severe Jaundice

20 Chapter 20: Acute Pulmonary & Airway Emergencies

20.1 Acute Hypoxic Respiratory Failure & ARDS 20.2 Severe Community-Acquired Pneumonia & Empyema 20.3 Acute Severe Epistaxis & Airway Obstruction

21 Chapter 21: Acute Traumatic Injuries & Wound Care

21.1 Major Trauma Resuscitation & Initial Assessment 21.2 Burn Assessment, Inhalation Injury & Resuscitation 21.3 Laceration Management, Complex Wounds & Animal Bites

22 Chapter 22: Acute Orthopedic & Musculoskeletal Emergencies

22.1 Acute Ambulatory Fractures & Initial Splinting 22.2 Compartment Syndrome & Major Orthopedic Trauma 22.3 Septic Arthritis & Acute Microcrystalline Crises

23 Chapter 23: Severe Infections, Sepsis & Systemic Emergencies

23.1 Sepsis, Septic Shock & Initial Fluid Resuscitation 23.2 Necrotizing Soft Tissue Infections & Severe CNS Infections 23.3 Anaphylaxis Diagnosis, Epinephrine Dosing & Airway Protection

24 Chapter 24: Metabolic, Endocrine & Electrolyte Emergencies

24.1 Diabetic Ketoacidosis & Hyperosmolar Hyperglycemic State 24.2 Critical Electrolyte Emergencies: Dyskalemias & Dysnatremias 24.3 Severe Calcium Abnormalities & Acute Adrenal Crisis

25 Chapter 25: Hematologic, Urologic & Dental Emergencies

25.1 Severe Symptomatic Anemias & Coagulopathic Emergencies 25.2 Testicular Torsion, Priapism & Acute Urinary Retention 25.3 Urgent Odontogenic Infections & Dental Trauma

26 Chapter 26: Psychiatric, Behavioral & Obstetric/Gynecologic Emergencies

26.1 Suicidal Ideation, Acute Agitation & Behavioral Emergencies 26.2 Acute Physical & Sexual Assault Care 26.3 Life-Threatening Vaginal Bleeding & Ectopic Pregnancy 26.4 Environmental Heat Stroke & Severe Hypothermia

27 Chapter 27: Acute Head, Neck & Neurologic Symptoms

27.1 Primary Acute Headaches: Migraine, Tension & Cluster 27.2 Concussion & Minor Closed Head Injury Evaluation 27.3 Transient Ischemic Attack Evaluation & ABCD2 Risk Scoring

28 Chapter 28: Acute Cranial Nerves, Hearing & Sensory Symptoms

28.1 Peripheral Neuropathies: Bell's Palsy, Carpal Tunnel & Radiculopathy 28.2 Acute Tinnitus, Sudden Sensorineural Hearing Loss & Cerumen Impaction 28.3 Acute Dizziness, Benign Paroxysmal Positional Vertigo & Vestibular Neuritis

29 Chapter 29: Acute Upper Respiratory Tract Infections

29.1 Acute Viral Rhinosinusitis vs. Bacterial Rhinosinusitis 29.2 Acute Pharyngitis: Group A Streptococcus & Centor Criteria 29.3 Acute Otitis Media, Otitis Externa & Serous Effusion

30 Chapter 30: Acute Lower Respiratory Infections & Cough

30.1 Influenza, COVID-19 & Viral Respiratory Syndromes 30.2 Acute Bronchitis & Lower Respiratory Tract Infections 30.3 Ambulatory Community-Acquired Pneumonia

31 Chapter 31: Allergic, Nasal & Non-Infectious Pulmonary Conditions

31.1 Allergic Rhinitis & Acute Non-Anaphylactic Allergic Reactions 31.2 Acute Dyspnea in Ambulatory Care 31.3 Interstitial Lung Diseases & Sarcoidosis Presentation

32 Chapter 32: Acute Chest, Cardiac & Vascular Symptoms

32.1 Palpitations Evaluation & Arrhythmia Triage in Primary Care 32.2 Deep Vein Thrombosis & Superficial Thrombophlebitis 32.3 Ambulatory Hypotension & Orthostasis Evaluation

33 Chapter 33: Acute Upper Gastrointestinal Conditions

33.1 Peptic Ulcer Disease & Gastritis 33.2 Dysphagia, Esophagitis & Acute Esophageal Disorders 33.3 Acute Nausea, Vomiting & Foodborne Illness

34 Chapter 34: Acute Lower Gastrointestinal Conditions

34.1 Acute Infectious Diarrhea & Gastroenteritis 34.2 Acute Constipation & Functional Bowel Changes 34.3 Ano-Rectal Disorders: Hemorrhoids, Fissures, Abscesses & Pruritus Ani

35 Chapter 35: Inflammatory, Functional & Malabsorptive GI Disorders

35.1 Acute Flares of Inflammatory Bowel Disease 35.2 Irritable Bowel Syndrome: Diagnosis, Subtyping & Management 35.3 Celiac Disease & Malabsorption Syndromes

36 Chapter 36: Acute Abdominal, Hepatic & Biliary Disorders

36.1 Ambulatory Abdominal & Pelvic Pain Triage 36.2 Acute Cholecystitis, Biliary Colic & Pancreatitis 36.3 Acute Liver Injury & Viral Hepatitis

37 Chapter 37: Acute Abdominal Wall, Hernias & Dental Conditions

37.1 Abdominal Wall, Inguinal & Ventral Hernias 37.2 Acute Dental Pain, Odontogenic Abscess & Aphthous Ulcers 37.3 Acute Edema: Unilateral vs. Bilateral Diagnostic Evaluation

38 Chapter 38: Acute Infectious Dermatoses

38.1 Bacterial Skin Infections: Impetigo, Cellulitis & Cutaneous Abscesses 38.2 Fungal Skin Infections: Tinea Corporis, Cruris, Pedis & Onychomycosis 38.3 Viral Cutaneous Infections: Herpes Simplex, Zoster & Molluscum Contagiosum

39 Chapter 39: Inflammatory, Allergic & Autoimmune Dermatoses

39.1 Atopic Dermatitis, Contact Dermatitis & Eczematous Flares 39.2 Non-Infectious Rashes: Urticaria, Drug Eruptions & Erythema Multiforme 39.3 Cutaneous Malignancies & Premalignant Lesions: AK, BCC, SCC & Melanoma

40 Chapter 40: Acute Shoulder, Elbow & Upper Extremity Injuries

40.1 Rotator Cuff Pathology, Tendinopathy & Shoulder Impingement 40.2 Lateral & Medial Epicondylitis, Olecranon Bursitis & Elbow Sprains 40.3 Wrist & Hand Soft-Tissue Injuries: De Quervain, TFCC & Finger Sprains

41 Chapter 41: Acute Knee, Ankle & Lower Extremity Injuries

41.1 Meniscal Tears, Ligamentous Knee Injuries & Patellofemoral Pain 41.2 Ankle Sprains, Ottawa Ankle Rules & Achilles Tendinopathy 41.3 Plantar Fasciitis, Shin Splints & Overuse Syndromes

42 Chapter 42: Acute Ambulatory Fractures & Dislocations

42.1 Distal Radius, Scaphoid & Common Upper Extremity Fractures 42.2 Metatarsal, Clavicle & Common Lower Extremity Fractures 42.3 Joint Dislocation Management: Nursemaid's Elbow & Shoulder Subluxation

43 Chapter 43: Acute Axial Musculoskeletal Pain & Falls

43.1 Acute Low Back Pain: Red Flags, Strain & Disc Herniation 43.2 Acute Cervical Strain, Whiplash & Axial Neck Pain 43.3 Evaluation of Falls in Ambulatory & Older Patients

44 Chapter 44: Acute Inflammatory Arthropathies & Generalized Pain

44.1 Acute Inflammatory Arthritis & Spondyloarthropathies 44.2 Myalgias, Rhabdomyolysis & Post-Viral Pain Syndromes 44.3 Acute Non-Headache Pain Management Strategies

45 Chapter 45: Acute Renal, Urinary & Genitourinary Conditions

45.1 Uncomplicated UTI, Pyelonephritis & Acute Urethritis 45.2 Hematuria Workup & Glomerulonephritis 45.3 Nephrolithiasis & Acute Urinary Tract Obstruction

46 Chapter 46: Acute Male Genitourinary & Prostatic Conditions

46.1 Acute Prostatitis, Epididymitis & Orchitis 46.2 Acute Scrotal Pain: Torsion vs Appendage, BPH & Male Genital Emergencies 46.3 Acute Urinary Retention & Incontinence Evaluation

47 Chapter 47: Acute Women's Health & Early Pregnancy Care

47.1 Early Pregnancy Diagnosis, Dating & Initial Complications 47.2 Abnormal Uterine Bleeding & Acute Menstrual Disorders 47.3 Premenstrual Syndrome & Premenstrual Dysphoric Disorder

48 Chapter 48: Breast Disorders, STIs & Pediatric Elimination

48.1 Palpable Breast Mass, Mastitis & Nipple Discharge 48.2 Sexually Transmitted Infections: Diagnosis, Staging & CDC Guidelines 48.3 Pediatric Enuresis & Encopresis

49 Chapter 49: Systemic Signs, Metabolic Dysregulation & Miscellaneous Infections

49.1 Acute Fever, Sepsis Screening & FUO in Primary Care 49.2 Acute Hyperglycemia & Symptomatic Hypoglycemia 49.3 Electrolyte Abnormalities: Mild-to-Moderate Disturbances 49.4 Vector-Borne, Tick-Borne & Rickettsial Illnesses

50 Chapter 50: Chronic Cardiovascular Diseases: Hypertension & Ischemia

50.1 Essential Hypertension Management: 2025 AHA/ACC Guideline & JNC Strategies 50.2 Chronic Coronary Artery Disease & Post-MI Secondary Prevention 50.3 Chronic Heart Failure: HFrEF, HFpEF & Quadruple GDMT

51 Chapter 51: Chronic Vascular, Valvular & Dyslipidemic Diseases

51.1 Peripheral Arterial Disease & Claudication 51.2 Chronic Valvular Heart Disease & Murmur Evaluation 51.3 Lipid Disorders & ASCVD Risk-Based Statin Therapy

52 Chapter 52: Chronic Respiratory Diseases: Asthma & COPD

52.1 Chronic Asthma Management: GINA Stepwise SMART Therapy 52.2 Chronic Obstructive Pulmonary Disease: GOLD Recommendations 52.3 Solitary Pulmonary Nodule Evaluation & Fleischner Society Criteria

53 Chapter 53: Chronic Metabolic Diseases: Diabetes Mellitus

53.1 Type 2 Diabetes Management: ADA Pharmacotherapy Algorithms 53.2 Type 1 Diabetes: Basal-Bolus Insulin, CGMs & Diabetic Complications 53.3 Diabetic Microvascular & Macrovascular Disease Surveillance

54 Chapter 54: Obesity, Nutrition & Metabolic Bone Diseases

54.1 Medical & Behavioral Management of Obesity & Incretin Mimetics 54.2 Osteoporosis & Metabolic Bone Disease: DEXA, FRAX & Antiresorptives 54.3 Nutritional Deficiencies: Vitamin D, B12, Iron & Malnutrition

55 Chapter 55: Chronic Endocrine Disorders

55.1 Primary & Subclinical Hypothyroidism, Hyperthyroidism & Nodules 55.2 Adrenal Disorders: Addison's Disease & Cushing's Syndrome 55.3 Hypercalcemia, Hyperparathyroidism & Pituitary Disorders

56 Chapter 56: Chronic Kidney Disease & Venous Disorders

56.1 Chronic Kidney Disease: KDIGO Staging & Renoprotective Therapy 56.2 Chronic Venous Insufficiency, Stasis Dermatitis & Lymphedema 56.3 Chronic Electrolyte & Acid-Base Management in CKD

57 Chapter 57: Chronic Gastrointestinal & Hepatic Diseases

57.1 Gastroesophageal Reflux Disease, Barrett's Esophagus & Dyspepsia 57.2 Chronic Liver Disease: MASLD/NAFLD, Cirrhosis & Portal Hypertension 57.3 Viral Hepatitis B & C: Long-Term Monitoring & DAA Therapy

58 Chapter 58: Colorectal Surveillance & Chronic Pancreaticobiliary Care

58.1 Post-Polypectomy Colorectal Polyp Surveillance Guidelines 58.2 Chronic Pancreatitis & Exocrine Pancreatic Insufficiency 58.3 Chronic Nausea, Gastroparesis & Functional GI Disorders

59 Chapter 59: Chronic Musculoskeletal & Rheumatologic Disorders

59.1 Osteoarthritis: Hip, Knee & Hand Management 59.2 Spinal Conditions: Spinal Stenosis, Spondylolisthesis & Compression Fractures 59.3 Chronic Myopathies & Fibromyalgia Syndrome

60 Chapter 60: Chronic Neurologic & Neurodegenerative Disorders

60.1 Dementia: Alzheimer's, Vascular & Lewy Body Disease 60.2 Parkinson's Disease & Essential Tremor 60.3 Epilepsy: Chronic Antiseizure Medications & Post-Stroke Care

61 Chapter 61: Chronic Peripheral Nerves, Pain & Sensory Disorders

61.1 Diabetic & Chronic Peripheral Neuropathies 61.2 Chronic Pain Syndromes & Chronic Daily Headaches 61.3 Chronic Tinnitus, Presbycusis & Persistent Dizziness

62 Chapter 62: Chronic Psychiatric Disorders

62.1 Major Depressive Disorder & Generalized Anxiety Disorder 62.2 Bipolar Disorder: Maintenance Pharmacotherapy & Lithium Monitoring 62.3 Adult & Pediatric Attention-Deficit/Hyperactivity Disorder

63 Chapter 63: Chronic Behavioral Health & Neurodevelopmental Conditions

63.1 Chronic Behavioral Conditions: PTSD, OCD & Somatization 63.2 Autism Spectrum Disorder & Intellectual Disabilities 63.3 Eating Disorders: Anorexia Nervosa, Bulimia & Binge Eating

64 Chapter 64: Chronic Substance Use Disorders & Tobacco Cessation

64.1 Alcohol Use Disorder: Pharmacotherapy & Relapse Prevention 64.2 Opioid & Stimulant Use Disorders: MOUD & Harm Reduction 64.3 Longitudinal Tobacco Cessation Pharmacotherapy

65 Chapter 65: Chronic Dermatologic Conditions

65.1 Acne Vulgaris, Rosacea & Seborrheic Dermatitis 65.2 Chronic Plaque Psoriasis & Biologic Therapies 65.3 Chronic Eczema, Hidradenitis Suppurativa & Cutaneous Lupus

66 Chapter 66: Chronic Reproductive, Infectious & Geriatric Special Care

66.1 Chronic Menstrual Disorders, Infertility & Sexual Dysfunction 66.2 Menopause Management & Hormone Replacement Therapy 66.3 Chronic HIV Infection Management & Primary Care Integration 66.4 Gender-Affirming Primary Care & Hormone Therapy 66.5 Advance Care Planning, Palliative Care & End-of-Life Symptom Control

67 Chapter 67: Continuity Care: Sleep, Fatigue, Cancer, Pregnancy & the Adult Preventive Visit

67.1 Chronic Insomnia & Obstructive Sleep Apnea 67.2 Chronic Malaise, Fatigue & ME/CFS 67.3 Primary Care During Cancer Treatment & Survivorship 67.4 Routine Prenatal Care & Longitudinal Pregnancy Management 67.5 The Periodic Adult Health Examination & Medicare Annual Wellness Visit

51.2 Chronic Valvular Heart Disease & Murmur Evaluation

Key Takeaways Explain This Topic AI

Severe Aortic Stenosis (AS) is defined by an aortic valve area (AVA) <=1.0 cm2, a mean transvalvular gradient >=40 mmHg, or a peak aortic jet velocity >=4.0 m/s; the onset of cardinal symptoms marks a precipitous decline in average survival: Angina (5 years), Syncope (3 years), and Heart Failure (2 years), mandating prompt SAVR or TAVI.

Physical examination hallmarks of severe AS include pulsus parvus et tardus (diminished amplitude and delayed peak of the carotid upstroke), a late-peaking harsh systolic crescendo-decrescendo murmur at the RUSB radiating to the carotids, single or paradoxical splitting of S2, and a diminished or absent A2 component.

All diastolic murmurs are pathologic and mandate a transthoracic echocardiogram; chronic Aortic Regurgitation is distinguished by a wide pulse pressure and peripheral hyperdynamic signs (Corrigan water-hammer pulse, Quincke capillary pulsations, Duroziez sign), whereas Mitral Stenosis produces a loud S1, opening snap (OS), and low-pitched mid-diastolic rumble.

Mitral Valve Prolapse (MVP) produces a mid-systolic click and late systolic murmur that moves EARLIER in systole and lengthens with maneuvers that decrease left ventricular preload (standing, Valsalva strain), and moves LATER with maneuvers that increase preload or afterload (squatting, sustained handgrip).

Under 2021 AHA/ACC guidelines, antibiotic prophylaxis for infective endocarditis (Amoxicillin 2 g oral 30-60 min prior to dental procedures involving gingival manipulation) is restricted strictly to highest-risk conditions (prosthetic heart valves/rings, previous infective endocarditis, unrepaired cyanotic or recently repaired congenital heart disease, cardiac transplant valvulopathy) and is NO LONGER recommended for native valve disease or routine GI/GU procedures.

Last updated: September 2026

Bedside Physical Examination & Dynamic Auscultation Framework

Accurate bedside evaluation of cardiac murmurs remains one of the core clinical competencies in family medicine. Auscultation requires a systematic approach utilizing both the bell and diaphragm across the four classic anatomical cardiac landmarks:

• Aortic Area : Second right intercostal space (RUSB) at the sternal border;
• Pulmonic Area : Second left intercostal space (LUSB) at the sternal border;
• Tricuspid Area : Fourth and fifth left intercostal spaces at the lower left sternal border (LLSB);

Mitral Area (Apex) : Fifth left intercostal space at the midclavicular line.

Stethoscope Acoustic Principles: Bell vs. Diaphragm

Diaphragm : Applied firmly against the skin to filter out low-frequency noise; optimal for high-pitched acoustic events: normal S1 and S2 , systolic ejection murmurs ( aortic stenosis ), holosystolic murmurs ( mitral and tricuspid regurgitation ), early diastolic blowing murmurs ( aortic regurgitation ), and non-ejection systolic clicks.

Bell : Applied lightly against the skin (firm pressure stretches the skin, turning it into a diaphragm that attenuates low frequencies); optimal for low-frequency acoustic vibrations: the S3 and S4 gallops and the low-pitched mid-diastolic rumble of mitral stenosis .

Dynamic Auscultation Maneuvers

Physiological and pharmacologic maneuvers alter cardiac loading conditions (preload, afterload, or heart rate) to differentiate overlapping murmurs. HEMODYNAMIC EFFECTS OF DYNAMIC BEDSIDE MANEUVERS

• Maneuver Physiological Alteration Murmur Response & Clinical Utility
• ═════════════════════════════════════════════════════════════════════════════════════════════════════════
• Inspiration Increases venous return to right Increases ALL right-sided murmurs
• (Carvallo Sign) ventricle; decreases left return (TR, TS, PR, PS); left-sided murmurs soften

• Expiration Increases venous return to left Increases ALL left-sided murmurs
• atrium and ventricle (AS, MR, AR, MS); right-sided murmurs soften

Standing / Valsalva Decreases venous return (decreases Softens MOST murmurs (AS, MR, AR);

Strain (Phase II) LV preload & end-diastolic volume) EXCEPTIONS:

• HOCM: Becomes LOUDER (increased obstruction)
• MVP: Click & murmur move EARLIER; murmur lengthens

Squatting / Passive Increases venous return (increases Intensifies MOST murmurs (AS, MR, AR);

Leg Raise preload) & increases systemic afterload EXCEPTIONS:

• HOCM: Becomes SOFTER (decreased obstruction)
• MVP: Click & murmur move LATER; murmur shortens

• Sustained Handgrip Increases systemic vascular Intensifies REGURGITANT murmurs (MR, AR, VSD);
• (Isometric Exercise) resistance (increases afterload) Softens stenotic ejection murmurs (AS, HOCM)
• ═════════════════════════════════════════════════════════════════════════════════════════════════════════
• Systolic Murmurs: Aortic Stenosis (AS)

Aortic stenosis is the most prevalent valvular disease in developed nations, affecting 2% to 7% of adults older than 65 years.

Etiologies of Aortic Stenosis

Calcific Aortic Sclerosis / Degeneration : The predominant etiology in elderly adults (>70 to 75 years). Characterized by chronic endothelial injury, lipid accumulation, and active dystrophic calcification of an anatomically normal trileaflet aortic valve, sharing pathophysiological mechanisms with vascular atherosclerosis.

Congenital Bicuspid Aortic Valve : The most common congenital cardiac anomaly (occurring in 1% to 2% of the general population; male-to-female ratio 3:1). Abnormal shear stress across the asymmetric two-leaflet architecture accelerates calcific degeneration, causing severe stenosis to manifest two decades earlier than in trileaflet valves, typically presenting in adults aged 40 to 60 years . Strongly associated with thoracic aortic aneurysm, aortic dissection, and coarctation of the aorta.

Rheumatic Heart Disease : Prominent in developing countries; causes commissural fusion and leaflet thickening, almost universally accompanied by rheumatic mitral valve involvement.

Auscultatory Hallmarks

The Murmur : A harsh, raspy, crescendo-decrescendo (diamond-shaped) systolic ejection murmur heard loudest at the right second intercostal space (RUSB) . It radiates prominently upward into the bilateral carotid arteries (and suprasternal notch).

The Gallavardin Phenomenon : In elderly patients with rigid, calcified aortic valves, the high-frequency acoustic components of the stenosis murmur are transmitted through the ventricular septum to the cardiac apex, where the murmur sounds high-pitched, musical, and blowing, easily masquerading as mitral regurgitation. It is distinguished from MR because it does not radiate to the axilla and retains its crescendo-decrescendo profile with beat-to-beat variation following premature ventricular contractions (post-PVC beat increases AS murmur intensity due to increased filling time, whereas MR remains constant).

Physical Examination Hallmarks of Severe AS

Pulsus Parvus et Tardus : The carotid arterial pulse exhibits diminished amplitude ( parvus ) and a delayed, slow-rising systolic peak ( tardus ), auscultated and palpated simultaneously with the cardiac apex.

Late-Peaking Murmur : In mild AS, the murmur peaks early in systole. As stenosis becomes severe, left ventricular ejection time is prolonged, causing the peak intensity to shift progressively toward late systole.

Diminished or Absent A2 (Aortic Closure Sound) : Severe calcification immobilizes the aortic cusps, preventing crisp coaptation. A2 softens and eventually becomes inaudible.

Paradoxical (Reversed) Splitting of S2 : Because LV ejection through the stenotic orifice is severely delayed, aortic valve closure (A2) occurs abnormally late, following pulmonic valve closure (P2) during expiration. On inspiration, P2 is normally delayed, merging with the delayed A2 into a single S2 . On expiration, P2 occurs earlier, revealing a widely split S2.

S4 Gallop : Reflects vigorous atrial contraction into a non-compliant, concentrically hypertrophied left ventricle.

The Classic Symptom Triad & Natural History

Asymptomatic severe AS carries a low annual risk of sudden death (<1%). However, the onset of cardinal symptoms marks a catastrophic inflection point , after which survival plummets rapidly unless the valve is replaced:

Angina (Average 5-Year Survival) : Driven by severe LV hypertrophy, elevated LV wall tension, and compressed subendocardial capillaries, producing severe demand-supply myocardial ischemia even in the absence of epicardial CAD.

Exertional Syncope (Average 3-Year Survival) : During exertion, skeletal muscle vasodilation occurs normally, but cardiac output cannot increase across the fixed stenotic orifice, triggering acute cerebral hypoperfusion; also aggravated by exercise-induced activation of high-pressure LV baroreceptors triggering inappropriate systemic vasodilation and bradycardia (the Bezold-Jarisch reflex).

Dyspnea / Heart Failure (Average 2-Year Survival) : Reflects diastolic dysfunction with elevated LV filling pressures and pulmonary venous congestion, progressing to systolic decompensation. DIAGNOSTIC ECHOCARDIOGRAPHIC CRITERIA FOR AORTIC STENOSIS

• Severity Category Aortic Valve Area (AVA) Mean Pressure Gradient Peak Aortic Velocity (Vmax)
• ═════════════════════════════════════════════════════════════════════════════════════════════════════
• Aortic Sclerosis > 2.0 cm2 < 10 mmHg < 2.0 m/s (leaflet thickening)
• Mild AS > 1.5 cm2 < 20 mmHg 2.0 to 2.9 m/s
• Moderate AS 1.0 to 1.5 cm2 20 to 39 mmHg 3.0 to 3.9 m/s
• Severe AS <= 1.0 cm2 >= 40 mmHg >= 4.0 m/s
• (Indexed <= 0.6 cm2/m2)
• Very Severe AS <= 0.6 to 0.8 cm2 >= 60 mmHg >= 5.0 m/s
• ═════════════════════════════════════════════════════════════════════════════════════════════════════
• Definitive Management: TAVI vs. SAVR

Medical pharmacotherapy has no role in halting the progression of calcific AS (randomized trials confirm statins do not slow valve calcification). Vasodilators (nitrates, ACE inhibitors) must be used with extreme caution because afterload reduction in the presence of fixed outflow obstruction can precipitate profound hypotension and syncope.

Indications for Valve Replacement :

• All symptomatic patients with severe AS (angina, syncope, heart failure, or reduced exercise tolerance);
• Asymptomatic severe AS with left ventricular systolic dysfunction (LVEF < 50%) ;
• Asymptomatic severe AS undergoing other cardiac surgery (e.g., CABG);

Asymptomatic very severe AS (peak velocity >=5.0 m/s or mean gradient >=60 mmHg) or demonstrated exercise intolerance / fall in blood pressure on standardized exercise stress testing.

Modalities :

Transcatheter Aortic Valve Implantation (TAVI / TAVR) : Minimally invasive transfemoral catheter deployment; preferred in elderly patients (age >=75 to 80 years) or those with high/intermediate surgical risk.

Surgical Aortic Valve Replacement (SAVR) : Mechanical or bioprosthetic open surgical replacement; preferred in younger patients (age <65 to 70 years), bicuspid anatomy with aortopathy, or patients requiring concurrent surgical revascularization.

Surveillance of Asymptomatic Patients : Transthoracic echocardiography every 6 to 12 months for severe AS; every 1 to 2 years for moderate AS; every 3 to 5 years for mild AS.

• Systolic Murmurs: Mitral Regurgitation & Mitral Valve Prolapse
• 1. Chronic Mitral Regurgitation (MR)

Primary (Organic) MR : Intrinsic structural disease of the mitral valve apparatus (leaflets, chordae tendineae, papillary muscles, or annulus). Prototypic causes: myxomatous degeneration / MVP , flail leaflet from spontaneous chordal rupture, and infective endocarditis .

Secondary (Functional) MR : Leaflets and chordae are structurally normal; regurgitation is caused by left ventricular remodeling and geometric distortion . Ischemic cardiomyopathy (post-inferior MI with papillary muscle displacement) or dilated cardiomyopathy pulls the leaflets apart (apical tethering) and dilates the mitral annulus, preventing central coaptation.

Auscultation :

A high-pitched, blowing holosystolic (pansystolic) murmur heard loudest at the cardiac apex .

Radiates characteristically to the left axilla (for anterior leaflet defects radiating posterolaterally; posterior leaflet defects can radiate anteriorly to the base).

The murmur intensity is constant throughout systole, obscures S1, and ends at S2.

S3 Gallop : Common in severe chronic MR, reflecting volume-overload rapid filling into an enlarged left ventricle.

Lateral and downward displacement of the hyperdynamic apical impulse.

Definitive Management : Mitral valve surgical repair (preferred over replacement) is indicated for symptomatic severe chronic primary MR, or asymptomatic severe MR with LVEF <=60% or LV end-systolic diameter (LVESD) >=40 mm .

2. Mitral Valve Prolapse (MVP)

MVP affects 2% to 3% of the population and is characterized by myxomatous expansion of the spongiosa layer of the mitral valve leaflets with accumulation of glycosaminoglycans, causing the leaflets to billow superiorly into the left atrium during ventricular systole.

Auscultation :

A crisp, high-pitched mid-systolic non-ejection click (produced by sudden tensing of elongated chordae tendineae and billowing leaflets as intraventricular pressure rises);

Followed by a late systolic crescendo murmur of mitral regurgitation heard at the apex.

Dynamic Auscultation of MVP :

Maneuvers that DECREASE LV volume / preload (Standing, Valsalva strain Phase II) : The smaller ventricular chamber causes the redundant leaflets to buckle and prolapse earlier in systole . Consequently, the click moves earlier (closer to S1) and the murmur becomes longer in duration.

Maneuvers that INCREASE LV volume / afterload (Squatting, Handgrip) : The enlarged ventricular cavity keeps the leaflets aligned longer, delaying prolapse. Consequently, the click moves later (closer to S2) and the murmur becomes shorter and softer .

Diastolic Murmurs: Aortic Regurgitation & Mitral Stenosis

Caution

THE CARDINAL RULE OF DIASTOLIC MURMURS Unlike systolic murmurs, which can frequently be functional or "innocent" (e.g., flow murmurs of pregnancy, anemia, fever, or youth), ALL DIASTOLIC MURMURS ARE PATHOLOGIC UNTIL PROVEN OTHERWISE .

Any patient with an audible diastolic murmur MANDATES A TRANSTHORACIC ECHOCARDIOGRAM for definitive structural and hemodynamic evaluation.

1. Chronic Aortic Regurgitation (AR)

Etiologies :

Valvular Causes : Congenital bicuspid aortic valve, infective endocarditis, rheumatic heart disease.

Aortic Root Disease : Dilation of the aortic root and ascending aorta prevents leaflet coaptation: chronic systemic hypertension, ascending aortic aneurysm, Marfan syndrome , Loeys-Dietz syndrome , Ehlers-Danlos syndrome , syphilitic aortitis, and ankylosing spondylitis.

Auscultation :

A high-pitched, blowing, early decrescendo diastolic murmur .

Heard best at the left third and fourth intercostal spaces (Erb's point) along the sternal border (when caused by primary valvular disease) or along the right sternal border (when caused by aortic root dilation).

Auscultatory Maneuver : Enhanced by having the patient sit upright, lean forward, and hold their breath in full expiration with the diaphragm firmly pressed to the chest wall.

The Austin Flint Murmur : A low-pitched, rumbling mid-to-late diastolic murmur heard at the cardiac apex. It is caused by the retrograde regurgitant jet striking the anterior leaflet of the mitral valve, causing partial closure and functional inflow turbulence across an anatomically normal mitral valve. Differentiated from mitral stenosis because there is no opening snap and no loud S1.

Peripheral Hemodynamic Signs of Severe Chronic AR :

Severe chronic AR produces a massive stroke volume ejected into the aorta followed by torrential diastolic run-off back into the left ventricle, resulting in an extreme wide pulse pressure (e.g., BP 165/45 mmHg):

Corrigan (Water-Hammer) Pulse : Bounding, rapid arterial upstroke with sudden, precipitous diastolic collapse, felt prominently at the radial or brachial artery when elevated above the head.

Quincke Sign : Rhythmic, alternating flushing and blanching of the nail bed capillaries visible upon applying gentle pressure to the tip of the fingernail.

Traube Sign : Booming, loud, "pistol-shot" systolic sounds auscultated over the femoral arteries.

Duroziez Sign : A systolic murmur heard over the femoral artery with gentle proximal compression, and a diastolic murmur heard with gentle distal compression.

De Musset Sign : Rhythmic head bobbing synchronous with each cardiac cycle.

Müller Sign : Systolic pulsation of the uvula.

Hill Sign : Popliteal cuff systolic blood pressure exceeding brachial cuff systolic blood pressure by >20 mmHg (mild) or >60 mmHg (severe AR).

Indications for SAVR : Symptomatic severe AR, or asymptomatic severe AR with LVEF <=55% or marked LV dilation ( LV end-systolic diameter >50 mm ).

2. Mitral Stenosis (MS)

Etiology : Mitral stenosis is almost exclusively post-rheumatic in origin , resulting from acute rheumatic fever (ARF) caused by Group A beta-hemolytic streptococcal pharyngitis. A classic latent interval of 20 to 40 years separates the acute childhood infection from the onset of clinical symptoms.

Pathology : Chronic post-inflammatory changes lead to fibrous thickening of leaflets, fusion of the commissures, and chordal shortening, creating a rigid, funnel-shaped "fish-mouth" orifice.

Auscultation :

Loud S1 : High left atrial pressure holds the pliable leaflets wide open until the moment of ventricular contraction, slamming them shut forcefully.

Opening Snap (OS) : A sharp, high-pitched early diastolic sound following S2, produced by sudden deceleration and tensing of the fused mitral leaflets as they balloon into the LV under high left atrial pressure.

A2-OS Interval : The interval between aortic closure (A2) and the opening snap is inversely related to stenosis severity. A shorter A2-OS interval (<80 ms) reflects higher left atrial pressure snapping the valve open earlier in diastole, indicating more severe stenosis .

Mid-Diastolic Rumbling Murmur : A low-pitched, rumbling diastolic murmur with presystolic accentuation (in patients maintaining sinus rhythm). Heard best with the bell of the stethoscope placed lightly at the apex with the patient in the left lateral decubitus position during expiration.

Complications of Mitral Stenosis :

Severe Left Atrial Enlargement : High LA pressures cause massive atrial remodeling.

Atrial Fibrillation : Develops in >40% to 50% of patients. Loss of the atrial "kick" combined with rapid ventricular rates precipitates sudden hemodynamic collapse and pulmonary edema.

Systemic Thromboembolism : Sluggish flow in the giant left atrium and left atrial appendage creates a high risk of mural thrombus and stroke. All patients with MS and atrial fibrillation mandate anticoagulation , irrespective of their CHA2DS2-VASc score.

Pulmonary Hypertension & Hemoptysis : High retrograde pulmonary venous pressures induce reactive pulmonary arterial vasoconstriction. Rupture of engorged bronchial-pulmonary venous anastomoses causes massive hemoptysis ("pulmonary apoplexy").

Ortner Syndrome (Cardiovocal Syndrome) : Hoarseness caused by compression of the left recurrent laryngeal nerve between a massively dilated left atrium and the aorta.

Definitive Management : Percutaneous Mitral Balloon Commissurotomy (PMBC) is the procedure of choice for symptomatic severe MS (mitral valve area <=1.5 cm2) if leaflet morphology is favorable (Wilkins score <=8; pliable leaflets without extensive subvalvular calcification, absence of left atrial thrombus, and absence of significant mitral regurgitation). Surgical replacement is indicated if PMBC criteria are not met.

2021 AHA/ACC Infective Endocarditis Prophylaxis Guidelines

Historically, antibiotic prophylaxis was broadly administered to patients with a wide variety of native cardiac conditions. However, clinical trials and large epidemiological cohorts demonstrated that transient bacteremias resulting from routine daily activities (tooth brushing, flossing, chewing food) occur thousands of times per year and represent the overwhelming source of infective endocarditis (IE), whereas antibiotic prophylaxis prior to dental procedures prevents only an exceedingly small fraction of IE cases.

The Four High-Risk Cardiac Categories Qualifying for Prophylaxis

Under current 2021 AHA/ACC guidelines , antibiotic prophylaxis prior to high-risk dental procedures is STRICTLY RESTRICTED to patients with the highest risk of adverse outcomes or mortality from infective endocarditis:

Prosthetic Heart Valves or Prosthetic Material : Includes mechanical and bioprosthetic valves, transcatheter-implanted valves (TAVI), and prosthetic rings or annuloplasty bands used for valve repair;

Previous History of Infective Endocarditis (confers an exceptionally high recurrence and destruction rate);

Congenital Heart Disease (CHD) :

Unrepaired cyanotic CHD , including palliative shunts and conduits;

Completely repaired congenital heart defect with prosthetic material or device , whether placed by surgery or transcatheter intervention, during the first 6 months following the procedure (allowing time for endothelialization);

Repaired CHD with residual defects at or adjacent to the site of a prosthetic patch or prosthetic device (which inhibits full endothelialization);

Cardiac Transplant Recipients who develop cardiac valvulopathy. SUMMARY: WHO GETS INFECTIVE ENDOCARDITIS PROPHYLAXIS?

• PROPHYLAXIS INDICATED (High-Risk Conditions) PROPHYLAXIS NO LONGER INDICATED (Native Conditions)
• ═══════════════════════════════════════════════════════════════════════════════════════════════════════
• Prosthetic cardiac valves (mechanical/bioprosthetic) • Native bicuspid aortic valve (without prior IE)
• Prosthetic rings / bands / clips for valve repair • Calcific aortic stenosis / sclerosis
• PREVIOUS EPISODE OF INFECTIVE ENDOCARDITIS • Mitral valve prolapse (with or without MR)
• Unrepaired cyanotic congenital heart disease • Rheumatic heart disease
• Completely repaired CHD with prosthetic < 6 months • Hypertrophic cardiomyopathy (HOCM)
• Repaired CHD with residual defect near patch • Ventricular or atrial septal defects (repaired >6m)
• Cardiac transplant recipient with valvulopathy • Routine GI / GU procedures (Colonoscopy, EGD, Cysto)
• ═══════════════════════════════════════════════════════════════════════════════════════════════════════
• Qualifying Procedures

Dental Procedures : Indicated ONLY for dental procedures that involve manipulation of gingival tissue , the periapical region of teeth , or perforation of the oral mucosa (e.g., dental extractions, periodontal surgery, subgingival scaling, root canal instrumentation).

Non-Qualifying Procedures : Routine local anesthetic injections through non-infected tissue, taking dental radiographs, placement of removable appliances, shedding of deciduous teeth, or bleeding from trauma to the lips/oral mucosa.

GI and GU Procedures : Antibiotic prophylaxis is NO LONGER RECOMMENDED for routine gastrointestinal or genitourinary procedures (including upper endoscopy [EGD], colonoscopy, sigmoidoscopy, cystoscopy, or transurethral resection), even in patients with prosthetic heart valves.

Guideline-Directed Antibiotic Regimens

Administered as a single oral dose 30 to 60 minutes prior to the procedure :

First-Line Standard : Oral Amoxicillin 2 g (pediatric dosing: 50 mg/kg up to 2 g max).

Unable to Take Oral Medication : Intravenous or intramuscular Ampicillin 2 g OR Cefazolin/Ceftriaxone 1 g.

Allergic to Penicillins / Ampicillin :

Oral Cephalexin 2 g (pediatric: 50 mg/kg up to 2 g; provided there is no history of anaphylaxis, angioedema, or hives to penicillins);

Oral Azithromycin or Clarithromycin 500 mg (pediatric: 15 mg/kg up to 500 mg);

Oral Doxycycline 100 mg (pediatric: 2.2 mg/kg up to 100 mg).

Caution

CLINDAMYCIN IS NO LONGER RECOMMENDED FOR IE PROPHYLAXIS The AHA/ACC guidelines explicitly removed Clindamycin from the recommended IE prophylaxis regimens. Clindamycin administration was found to cause a disproportionate incidence of severe, fatal Clostridioides difficile colitis, while offering unreliable bactericidal efficacy against viridans group streptococci.

Loading diagram... Systematic Algorithm for Auscultatory Evaluation of Cardiac Murmurs